Masahiko Hayakawa

Pharmacologic Characterization of a Potent Inhibitor of Class I Phosphatidylinositide 3-Kinases

Florence I. Raynaud, Suzanne A. Eccles, Paul A. Clarke et al. · Cancer Research · 2007 · 352 citations · Full text

Medicine, Oncology, Pharmacology +10

A selective PIKfyve inhibitor blocks PtdIns(3,5)P2 production and disrupts endomembrane transport and retroviral budding

Harold B.J. Jefferies, Frank T. Cooke, Parmjit Jat et al. · EMBO Reports · 2008 · 302 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110α inhibitors

Masahiko Hayakawa, Hiroyuki Kaizawa, Hiroyuki Moritomo et al. · Bioorganic & Medicinal Chemistry · 2006 · 195 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Synthesis and biological evaluation of pyrido[3′,2′:4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110α inhibitors

Masahiko Hayakawa, Hiroyuki Kaizawa, Hiroyuki Moritomo et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 141 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Highly porous nature of a primitive asteroid revealed by thermal imaging

Tatsuaki Okada, Tetsuya Fukuhara, Satoshi Tanaka et al. · Nature · 2020 · 139 citations · Full text

Natural Sciences, Earth Sciences, Geology +16